Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?
Objective To assess the effect of cabergoline on endometrial vascular endothelial growth factor receptor-2 (VEGFR-2) immunoexpression in an ovarian hyperstimulation syndrome (OHSS) rat model.Material and Methods Twenty-one immature female Wistar rats were assigned into three groups: group 1, the con...
Saved in:
Main Authors: | Nafiye Yilmaz (Author), Pinar Gulsen Coban (Author), Saynur Yilmaz (Author), Hasan Ali Inal (Author), Hakan Timur (Author), Hacer Haltas (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
by: Eryn Sara Rubenfeld, et al.
Published: (2021) -
Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
by: Nikita Naredi, et al.
Published: (2013) -
Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2016) -
Expression of Concern: Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome
Published: (2024) -
Large-volume paracentesis, up to 27 L, with adjuvant vaginal cabergoline in the case of severe ovarian hyperstimulation syndrome with successful pregnancy outcome: A case report
by: Nupur Agarwal, et al.
Published: (2017)